ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



Paeoniflorin and paeonol from Paeonia species are promising compounds with anticancer and other pharmacological properties

Eric Wei Chiang Chan.



Abstract
Download PDF Post

In this short review, information on the anticancer properties of paeoniflorin (PF) and paeonol (PN) from Paeonia species is collated with reference to the types of cancer, cell lines, effects, and molecular processes. The chemistry, botany, and uses of Paeonia lactiflora and P. suffruticosa, where respective PF and PN are often isolated, are briefly described. PF is a monoterpene glucoside while PN is a phenolic compound. The chemical structure of PF consists of a glucose moiety, a benzoyl moiety, and a cage-like pinane skeleton. PN has a ketone carbonyl side chain at C1, an OH group at C2, and a methoxy component at C4. PF has effects on eight types of cancer cells of which glioma cells are most affected. Liver cancer cells are most affected by PN. In this overview, the anticancer properties of PF and PN against five types of cancer cells are described. Information entails cancer cell types, cancer cell lines, effects, and molecular mechanisms. Some further studies on the anticancer properties of PF and PN are suggested.

Key words: Chinese Peony, Moutan Peony, monoterpene glucosides, phenolic compound.







Bibliomed Article Statistics

35
35
36
30
19
27
26
6
R
E
A
D
S

25

18

14

8

14

15

11

2
D
O
W
N
L
O
A
D
S
0506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.